Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

23.59 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,136
Open 23.59
Bid (Size) 23.29 (2)
Ask (Size) 23.47 (1)
Prev. Close 23.59
Today's Range 23.59 - 23.59
52wk Range 5.650 - 25.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Look Into Hims & Hers Health Inc's Price Over Earnings
Via Benzinga
How Is The Market Feeling About Hims & Hers Health?
Via Benzinga

Performance

YTD
+144.71%
+144.71%
1 Month
+43.49%
+43.49%
3 Month
+3.60%
+3.60%
6 Month
+91.32%
+91.32%
1 Year
+281.10%
+281.10%

More News

Read More
This Is What Whales Are Betting On Hims & Hers Health
Via Benzinga
Decoding 6 Analyst Evaluations For Hims & Hers Health
Via Benzinga
Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
From Hims & Hers
Via Business Wire
In-Depth Examination Of 6 Analyst Recommendations For Hims & Hers Health
Via Benzinga
What Is Going On With Hims & Hers Stock?
Via The Motley Fool
Why Hims & Hers' Incredible Growth Will Continue
Via The Motley Fool
Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk.
Via Investor's Business Daily
Exposures Product Safety
Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024
From Hims & Hers
Via Business Wire
Hims & Hers Health Stock Is Popping Monday: What's Behind The Move?
Via Benzinga
Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
Via Investor's Business Daily
Topics Lawsuit
Exposures Financial Legal Product Safety
Where Does Hims & Hers Stock Go From Here?
Via The Motley Fool
Exposures Product Safety
2 Incredibly Cheap Growth Stocks to Buy Right Now
Via The Motley Fool
2 No-Brainer Growth Stocks to Buy With $500 Right Now
Via The Motley Fool
Top 3 Stocks with Explosive Call Option Activity: What to Watch
Via MarketBeat
FDA Sparks Controversy With Sudden Removal Of Eli Lilly's Weight Loss Drug From Shortage List
Via Benzinga
Exposures Product Safety
Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?
Via MarketBeat
Topics Stocks
Exposures US Equities
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
Via Benzinga
Hims & Hers Health Stock Is Rising Monday: What's Going On?
Via Benzinga
Topics Stocks
Exposures US Equities
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
Via Benzinga
Exposures Product Safety
Massive News for Hims & Hers Stock: The Truth About Today's Move
Via The Motley Fool
2 Winning Growth Stocks That Are Screaming Buys Right Now
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.